Using AI-ECG to Stratify Long-Term Mortality Risk and Prognosis in TAVR Patients.
TL;DR
The AI-ECG model provides noninvasive and accurate long-term risk stratification for TAVR patients, with promising clinical application value for individualized follow-up management.
Abstract
Background
Long-term mortality remains unsatisfactorily high after transcatheter aortic valve replacement (TAVR). Conventional risk models are limited in capturing subclinical electrophysiological alterations associated with poor prognosis, which can be identified on routine preoperative electrocardiograms.
Objectives
The authors aim to develop and validate an artificial intelligence-enhanced electrocardiogram (AI-ECG) model for predicting long-term mortality in post-TAVR patients.
Methods
A total of 711 patients with severe aortic stenosis undergoing TAVR were enrolled from 2 centers. Patients from one center were divided into training and internal validation sets (7:3), and participants from another center served as the external validation cohort. Preoperative electrocardiogram images were analyzed using a Residual Network-18 model to generate mortality risk stratification. The primary endpoint was 3-year all-cause death.
Results
The AI-ECG model demonstrated comparable discrimination between the internal and external patient cohorts, with areas under the receiver operating characteristics curve of 0.767 (95% CI: 0.657-0.877) vs 0.712 (95% CI: 0.627-0.795) (P for DeLong test = 0.428). High-risk patients (15.5% [39 of 251]) exhibited a 61.5% (24 of 39, 95% CI: 42.8%-74.1%) 3-year mortality rate vs 16.5% (35 of 212, 95% CI: 11.4%-21.4%) in low-risk patients (84.5% [212 of 251]) (log-rank P < 0.001). Adjusted for comorbidities, high-risk classification independently predicted mortality (adjusted HR: 3.49; 95% CI: 1.96-6.22). Subgroup analysis did not reveal significant interaction effects of the AI-ECG model across different patient populations. Decision curve analysis confirmed clinical net benefit across threshold probabilities (0.05-0.60).
Conclusions
The AI-ECG model provides noninvasive and accurate long-term risk stratification for TAVR patients, with promising clinical application value for individualized follow-up management.